|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/04 | |
| A61K 31/443 | |||
| A61K 31/4436 | |||
| A61K 31/501 | |||
| C07D 409/04 | |||
| C07D 471/04 |
| (11) | Number of the document | 2132201 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08724190.7 |
| Date of filing the European patent application | 2008-03-05 | |
| (97) | Date of publication of the European application | 2009-12-16 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SE2008/050243 |
| Date | 2008-03-05 |
| (87) | Number | WO 2008/108730 |
| Date | 2008-09-12 |
| (30) | Number | Date | Country code |
| 893149 P | 2007-03-06 | US |
| (72) |
ARZEL, Erwan, SE
SWAHN, Britt-Marie, SE
WENSBO, David, SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | NOVEL 2-HETEROARYL SUBSTITUTED BENZOTHIOPHENES AND BENZOFURANES |
| NOVEL 2-HETEROARYL SUBSTITUTED BENZOTHIOPHENES AND BENZOFURANES |